Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | F13A1 | P00488 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | CA4 | P22748 | 2/20 | 0.54 |
| ▸ | CA6 | P23280 | 2/20 | 0.54 |
| ▸ | CA5A | P35218 | 2/20 | 0.54 |
| ▸ | THPO | P40225 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.54 |
| ▸ | CASP2 | P42575 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27789136 | 0.98 | PAOX (0.70) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL25229942 | 0.98 | PAOX (0.77) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL183049 | 0.98 | PAOX (0.76) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL22171088 | 0.98 | PAOX (0.69) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL22171096 | 0.98 | PAOX (0.69) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Spermine SCHEMBL25409776 | 0.98 | PAOX (0.76) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Spermidine SCHEMBL10954114 | 0.96 | PAOX (0.80) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL183048 | 0.96 | PAOX (0.80) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Hydrochloric Acid SCHEMBL7517784 | 0.94 | PAOX (0.77) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Hydrochloric Acid SCHEMBL17292784 | 0.94 | PAOX (0.70) | PAOXKDM4EMAPK1HIF1ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099467-A1 | COMPOSITION FOR USE IN PROMOTING BRAIN DEVELOPMENT AND FUNCTIONING | Société des Produits Nestlé S.A. (CH) | 2026-05-15 | — | — | WO | claimed |
| WO-2026044253-A1 | GENETICALLY ENCODED FLUORESCENT SENSORS FOR VISUALIZING POLYAMINE LEVELS, UPTAKE, AND DISTRIBUTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-26 | — | — | WO | claimed |
| US-20240426830-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-12-26 | — | — | US | claimed |
| US-20240241107-A1 | SERUM METABOLOMICS RELATED TO CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-18 | — | — | US | claimed |
| CN-117915926-A | Serometabonomics associated with Chimeric Antigen Receptor (CAR) T cell therapy | 得克萨斯州大学系统董事会 | 2024-04-19 | — | — | CN | claimed |
| EP-4333860-A1 | SERUM METABOLOMICS RELATED TO CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY | Board of Regents, The University of Texas System (US) | 2024-03-13 | — | — | EP | claimed |
| US-20230390346-A1 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | BIOMEDIT, LLC | 2023-12-07 | — | — | US | claimed |
| EP-4216726-A1 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | Biomedit, LLC (US) | 2023-08-02 | — | — | EP | claimed |
| CN-116507349-A | Probiotic bacillus compositions and methods of use | 生物编辑有限责任公司 | 2023-07-28 | — | — | CN | claimed |
| WO-2023069598-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2023-04-27 | — | — | WO | claimed |
| EP-1221615-A2 | S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy | ORIDIGM CORPORATION (US) | 2002-07-10 | — | — | EP | claimed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | claimed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| CN-1231340-A | Anti-tumor antibiotic and microbiological formentation production method thereof | INST OF MEDICINAL AND BIOLOG T (CN) | 1999-10-13 | — | — | CN | claimed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| EP-0297533-B1 | Novel acetylpolyamine amidohydrolase | KYOWA HAKKO KOGYO KK (JP) | 1994-06-01 | — | — | EP | claimed |
| EP-0568338-A2 | Methods for the use of spermidine/spermine N'-acetyltransferase as a progonostic indicator and/or a tumor response marker | HEALTH RESEARCH, INC. (US) | 1993-11-03 | — | — | EP | claimed |
| US-4981788-A | BIOSYNTHESIS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-01-01 | — | — | US | claimed |
| EP-0297533-A2 | Novel acetylpolyamine amidohydrolase | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1989-01-04 | — | — | EP | claimed |
| US-4550078-A | ENZYMATIC OXIDATIVE DECOMPOSITION | AMANO SEIYAKU KABUSHIKI KAISHA (JP) | 1985-10-29 | — | — | US | claimed |